文献速递认知障碍与痴呆

衰弱对阿尔茨海默病神经病理与痴呆关系的调节作用

Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer's disease: a cross-sectional analysis of data from the Rush Memory and Aging Project.
PubMed 文献 · Lancet Neurol · 2019-01-01

该横断面分析基于Rush记忆与老化项目的456名参与者,旨在检验衰弱是否调节阿尔茨海默病病理与阿尔茨海默痴呆之间的关系。结果显示衰弱和阿尔茨海默病病理均独立与痴呆相关,且两者存在显著交互作用,衰弱程度越高,病理与痴呆的直接联系越弱。

要点

  • 衰弱与阿尔茨海默病病理均独立增加痴呆风险。
  • 衰弱与病理存在交互作用,衰弱高者病理更易表达为痴呆。
  • 衰弱程度影响同等年龄下病理与痴呆的关联强度。

核心结论

  • 衰弱程度在同龄人群中调节阿尔茨海默病病理与阿尔茨海默痴呆之间的关联。

研究设计与样本

  • 阿尔茨海默病病理通过神经原纤维缠结和斑块的汇总指标量化,痴呆诊断基于临床共识。
  • 衰弱采用41项衰弱指数回顾性操作化,使用逻辑回归和调节模型分析,并调整年龄、性别和教育。

主要发现

  • 242名(53%)在最后一次临床评估时诊断为可能或很可能阿尔茨海默痴呆。

临床怎么用

  • 临床管理需考虑衰弱程度,即使低水平病理,高衰弱者也可能面临痴呆风险。

局限性

  • 横断面设计无法评估衰弱和认知随时间的变化,需进一步研究阐明复杂关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Some people with substantial Alzheimer's disease pathology at autopsy had shown few characteristic clinical symptoms or signs of the disease, whereas others with little Alzheimer's disease pathology have been diagnosed with Alzheimer's dementia. We aimed to examine whether frailty, which is associated with both age and dementia, moderates the relationship between Alzheimer's disease pathology and Alzheimer's dementia. METHODS: We did a cross-sectional analysis of data from participants of the Rush Memory and Aging Project, a clinical-pathological cohort study of older adults (older than 59 years) without known dementia at baseline, living in Illinois, USA. Participants in the cohort study underwent annual neuropsychological and clinical evaluations. In the present cross-sectional analysis, we included those participants who did not have any form of dementia or who had Alzheimer's dementia at the time of their last clinical assessment and who had died and for whom complete autopsy data were available. Alzheimer's disease pathology was quantified by a summary measure of neurofibrillary tangles and neuritic and diffuse plaques. Clinical diagnosis of Alzheimer's dementia was based on clinician consensus. Frailty was operationalised retrospectively using health variable information obtained at each clincial evaluation using the deficit accumulation approach (41-item frailty index). Logistic regression and moderation modelling were used to assess relationships between Alzheimer's disease pathology, frailty, and Alzheimer's dementia. All analyses were adjusted for age, sex, and education. FINDINGS: Up to data cutoff (Jan 20, 2017), we included 456 participants (mean age at death 89·7 years [SD 6·1]; 316 [69%] women). 242 (53%) had a diagnosis of possible or probable Alzheimer's dementia at their last clinical assessment. Frailty (odds ratio 1·76, 95% CI 1·54-2·02; p<0·0001) and Alzheimer's disease pathology (4·81, 3·31-7·01; p<0·0001) were independently associated with Alzheimer's dementia, after adjusting for age, sex, and education. When frailty was added to the model for the relationship between Alzheimer's disease pathology and Alzheimer's dementia, model fit improved (p<0·0001). There was a significant interaction between frailty and Alzheimer's disease pathology (odds ratio 0·73, 95% CI 0·57-0·94; pinteraction=0·015). People with an increased frailty score had a weakened direct link between Alzheimer's disease pathology and Alzheimer's dementia; that is, people with a low amount of frailty were better able to tolerate Alzheimer's disease pathology, whereas those with higher amounts of frailty were more likely both to have more Alzheimer's disease pathology and for it to be expressed as dementia. INTERPRETATION: The degree of frailty among people of the same age modifies the association between Alzheimer's disease pathology and Alzheimer's dementia. That frailty is related to both odds of Alzheimer's dementia and disease expression has implications for clinical management, since individuals with even a low level of Alzheimer's disease pathology might be at risk for dementia if they have high amounts of frailty. Further research should assess how frailty and cognition change over time to better elucidate this complex relationship. FUNDING: None.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Wallace LMK, Theou O, Godin J, et al. Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer's disease: a cross-sectional analysis of data from the Rush Memory and Aging Project. Lancet Neurol. 2019. PMID: 30663607. doi:10.1016/S1474-4422(18)30371-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。